MONTELUKAST ZENTIVA 4 mg, granules in a sachet 28 sachets
Active ingredients: Montelukast, Montelukast sodium
Commercialized according to BDPMDispensing in France: Prescription only
Granules28 sachetsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- MONTELUKAST ZENTIVA 4 mg, granulés en sachet
- Pharmaceutical form
- granulés
- Route of administration
- orale
- Presentation description
- 28 sachets polytéréphtalate (PET) aluminium polyéthylène basse densité (PEBD)
- Marketing authorisation holder
- ZENTIVA FRANCE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 7 Mar 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63708831CIP73028957CIP133400930289570Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MONTÉLUKASTgranulés | 4 mg · un sachet-dose | FT |
| MONTÉLUKAST SODIQUEgranulés | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.